MARK OLDAKOWSKI - 12 May 2021 Form 4 Insider Report for Bionano Genomics, Inc (BNGO)

Role
Chief Operating Officer
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
12 May 2021
Transactions value $
$0
Form type
4
Filing time
14 May 2021, 19:15:30 UTC
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Award $0 +240K +1985.77% $0.00 252K 12 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
F2 Includes: 495 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on December 10, 2018, 1,021 shares acquired under the ESPP on June 10, 2019, 1,405 shares acquired under the ESPP on December 10, 2019, 1,199 shares acquired under the ESPP on June 10, 2020 and 1,151 shares acquired under the ESPP on December 10, 2020.